A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents with Mild to Moderate Asthma

Trial Identifier: D5180C00002
Sponsor: MedImmune, LLC
Collaborator:
Amgen Inc.
NCTID:: NCT02512900
Start Date: September 2015
Primary Completion Date: May 2016
Study Completion Date: May 2016
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Poland Kielce, Poland, 25-040
Poland Łódź, Poland, 71-329
Poland Wrocław, Poland, 53-201
Poland Wrocław, Poland, 51-162